Browsing Tag
Imugene Limited
6 posts
Imugene (ASX:IMU) jumps 19% as azer-cel opportunity meets a funding reset
Imugene Limited shares jumped 18.92% to A$0.044 on October 5 as trading activity accelerated from a 52-week low. The rebound puts azer-cel, Imugene's sharply reduced cost base and its recently replenished funding runway back in focus.
ASX top 10 gainers on October 5, 2026: 333D soars 80% as small caps rally
333D Limited surged 80% to lead the ASX top gainers on October 5, 2026, while Sequoia Financial Group Limited, Imugene Limited and a cluster of mining stocks recorded double-digit intraday gains.
$IMU rises after Imugene wins FDA Fast Track status for allogeneic CAR T therapy in CLL and MZL
Imugene won FDA Fast Track status for azer-cel in blood cancers. Find out what the $IMU regulatory boost means for investors.
Is Imugene’s 17% stock slump an overreaction to dilution or a warning sign for CAR T investors?
Imugene shares fell 17% after a $37.5M raise, but can Fast Track and strong azer-cel data make the drop a buying opportunity for CAR T investors?
Imugene’s A$37.5m capital raise fuels pivotal azer-cel trial plans as stock tumbles 17%
Imugene raises A$37.5M to fund pivotal azer-cel trial in 2026. Can its off-the-shelf CAR T therapy deliver on its $2B market promise?
Game-changing cancer therapy: Imugene’s VAXINIA receives FDA orphan drug status for bile tract cancer
Imugene Limited has received a significant boost with the United States Food and Drug Administration (FDA) granting Orphan…